Acitretin Market Size

Acitretin Market Size

Acitretin Market size was valued at around USD 33.8 million in 2023 and is estimated to grow at 4.6% CAGR from 2024 to 2032. Acitretin is a pharmaceutical agent belonging to the class of retinoids, derivatives of vitamin A. It is primarily used in the treatment of severe psoriasis, a chronic inflammatory skin disorder characterized by thickened, scaly patches of skin. Acitretin is available in oral capsule form and works by modulating the growth and development of skin cells, reducing inflammation, and promoting the shedding of excess skin cells.

The increasing prevalence of psoriasis and psoriasis treatment serves as a substantial impetus for market growth. For instance, according to information sourced from the National Library of Medicine in 2021, the prevalence of psoriasis varies, with rates in adults ranging from 0.91% to 8.5%, and in children 2.1%. Globally, an estimated 125 million people, constituting approximately 2–3% of the total population are affected by psoriasis. Thus, this underscores the significant demand for effective treatment options such as acitretin, driving market growth for medications targeting psoriasis management. Furthermore, advancements in treatment, expanding healthcare infrastructure, and growing awareness and diagnosis are the contributing factors stimulating the growth of the market.